EDGAR Filing Documents for 0001178913-24-003951

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001178913-24-003951

Filing Date

2024-12-10

Accepted

2024-12-10 07:03:32

Documents

Period of Report

2024-12-10

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	zk2432448.htm	6-K	37921
2		image00002.jpg	GRAPHIC	4218
	Complete submission text file	0001178913-24-003951.txt		44843

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739

Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131

RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 241537118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)